1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow IFL protocol: new trials by email Literature Review of IFL protocol trials Research Report on IFL protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI FOLFIRI Protocol, SCO-101 - Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Unknown | Scandion Oncology A/S | 35 | 2020-05-14 | 2022-03-02 |
Colorectal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Denmark (1) · Germany (1) · Spain (1)